GTR Home > Tests > Search results - Fanconi anemia, complementation group D2

Apply filters

Showing test for 1 condition

reset

Compare labs

Your search term can be found in tests with a total of 1723 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

  • Hide states

GTR test search results for C3160738[DISCUI]

C Clinical test, R Research test

Showing 1 to 17 of 17 tests for 1 condition in 9 labs

CFanconi anemia type D2

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CTruGenome Predisposition Screen (Whole Genome Sequencing)

Lab: Illumina Clinical Services Laboratory Illumina San Diego, California, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (1541)
Total targets (1578)

CFanconi Anemia via the FANCD2 Gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CFanconi Anemia Sanger Sequencing Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (14)
Total targets (14)

CFanconi Anemia NextGen Sequencing Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (16)
Total targets (16)

CFanconi anemia Panel

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (17)
Total targets (16)

CFanconi anemia type D2 (sequence analysis of FANCD2 gene)

Lab: CGC Genetics Porto, Porto, Portugal
Test targets
Methods
  • C Sequence analysis of the entire coding region

CFanconi Anemia Sequencing Panel

Lab: Genetic Services Laboratory University of Chicago Chicago, Illinois, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (18)
Total targets (17)

CCancer Predisposition

Lab: Asper Biotech Asper Biotech Ltd. Tartu, Tartumaa, Estonia
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (134)
Total targets (100)

CFANCD2

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CFanconi anemia (NGS panel for 15 genes)

Lab: CGC Genetics Porto, Porto, Portugal
Total conditions (14)
Total targets (15)

CFANCD2 Sequencing

Test targets
Methods
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CHereditary Cancer NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (256)
Total targets (112)

CFanconi Anemia NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (36)
Total targets (16)

CFanconi Anemia Panel by next-generation sequencing (NGS)

Test targets
Methods
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (16)
Total targets (16)

CBone Marrow Failure Syndromes Panel by next-generation sequencing (NGS)

Test targets
Methods
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (47)
Total targets (59)

CBreast and Ovarian Cancer

Lab: Asper Biotech Asper Biotech Ltd. Tartu, Tartumaa, Estonia
Test targets
Methods
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (20)
Total targets (33)

Showing 1 to 17 of 17 tests for 1 condition in 9 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.